Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Freeline Therapeutics
Biotech
Syncona throws lifeline to Freeline by buying struggling biotech
After mulling a potential buyout for a month, Freeline Therapeutics has decided that its future lies in the arms of its majority shareholder.
James Waldron
Nov 22, 2023 9:40am
Freeline, facing fading cash runway, mulls buyout by Syncona
Oct 19, 2023 10:00am
Freeline cans another 30% of its staff months after last layoffs
Apr 4, 2023 8:45am
Syncona blames biotech bear market for 'disappointing' returns
Feb 7, 2023 10:31am
Adamis, Harpoon, Neoleukin and Tricida grow biotech layoff wave
Nov 15, 2022 6:45am
Romanelli returns to Merck after brief CEO role—Chutes & Ladders
Apr 22, 2022 9:30am